Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Tolerability and Efficacy of Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial

NCT03380728 is registered in ClinicalTrials.gov with University of Sao Paulo as lead sponsor.

NCT NCT03380728
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03380728 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Tolerability and Efficacy of Ibogaine in the Treatment of Alcoholism: an Open-label Escalating-dose Trial
Lead sponsor
University of Sao Paulo
Phase
Phase 2
Overall status
Completed
Start date
October 30, 2022
Completion date
October 30, 2024
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcoholism